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Abstract
Background: Pain and discomfort related to endoscopy sessions can be alleviated by sedation, which minimizes
anxiety and allows safe examination. For outpatient endoscopy, reliable short-term sedation without secondary
effects is required. This study aimed to assess the effects of intravenous propofol rates on sedation in outpatients
undergoing upper gastrointestinal endoscopy.
Methods: This randomized prospective study evaluated 300 outpatients submitted to upper gastrointestinal
endoscopy. Patients received propofol at 500, 1000 or 2000 ml/h. The primary outcome assessed was hypoxemia
incidence. In addition, time to sedation and incidence of hypotension, deep sedation, extremity motor activity,
cough, nausea, hiccough, and awareness were evaluated.
Results: Recovery time and incidence of hypoxemia, hypotension, and deep sedation were significantly increased
in individuals treated at 2000 ml/h in comparison with values obtained for 500 and 1000 ml/h groups (P < 0.01).
Compared with the 500 ml/h group, motor activity of the extremities, cough, nausea, hiccough, and awareness
were significantly decreased and the mean scores for endoscopist’s and patients’ satisfaction were significantly
increased in the 1000 and 2000 ml/h groups (P < 0.01).
Conclusion: Propofol infused at 1000 ml/h appeared to be the most suitable infusion rate for outpatient upper
gastrointestinal endoscopy.
Trial registration: Registration number: ChiCTR-TRC-14004786; Registration date: 2014-06-04
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Background
Pain and discomfort related to endoscopy sessions can
be alleviated by sedation, which minimizes anxiety and
allows safe examination [1]. Over 98 % of endoscopies
are performed under sedation [2, 3]. For outpatient
endoscopic procedures, reliable short term sedation
without secondary effects is required. Intravenous (IV)
propofol is frequently used [4, 5].
Propofol (2, 6-diisopropylphenol) is a hypnotic agent
that induces anesthesia in about 50 s at standard doses
[6]. Propofol is characterized by short half-life, rapid on-
set, important volume of distribution, and absence of ac-
tive metabolites, leading to rapid recovery and discharge.
These properties make propofol suitable for outpatient
gastrointestinal endoscopy.
Using the same dose, the final blood concentrations of
propofol depend on patient sex, age and weight, and drug
dose, administration rate, and cardiac output [7–10]. Pre-
vious studies have shown that the required doses for
anesthesia onset are affected by changes in the rate of
injection [7, 10, 11]. A previous study has shown that
the hypnotic peak effect of propofol is lower using a very
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slow injection rate (240 s), but there was no difference
when using clinically-used injection rates (5–120 s) [12].
Another study showed that the sleep dose of propofol is
reduced using slower infusion rates, while fast infusion
rates resulted in greater decreases in heart rate and higher
incidence of apnea [13]. The use of a slow infusion rate re-
sults in longer induction duration, but requires a lower
total dose, and results in a lower incidence of apnea and a
lesser decrease in blood pressure [14]. However, the ap-
propriate injection rate in an outpatient setting is still
controversial.
This study aimed to identify the most suitable propofol
infusion rate for outpatients submitted to upper gastro-
intestinal endoscopy that resulted in the lowest adverse




This randomized, parallel, controlled study was performed
at the Department of Anesthesia, Second Hospital, Jiaxing
Medical College (Jiaxing, Zhejiang, China) between June
2014 and August 2014 (registration number ChiCTR-
TRC-14004786). The procedures were approved by the
ethics review board of the Second Affiliated Hospital of
Jiaxing College, chaired by Professor Liqin Jiang (number
CZJ 65). Written informed consent was obtained from
each patient prior to participation.
Patients
For patient inclusion, the following criteria were set: 1)
American Society of Anesthesiologists (ASA) class I-III; 2)
upper gastrointestinal endoscopy; and 3) age 18–65 years.
Exclusion criteria were: 1) pregnancy; 2) allergies to eggs,
beans, or latex; 3) history of alcohol or sedative overdose
[15]; 4) history of adverse events associated with propofol;
5) sleep apnea or acute gastrointestinal hemorrhage; or 6)
recent abnormalities of the central nervous system such
as stroke.
Intervention
The patients were randomized to one of three groups
using a random number table. Patients were adminis-
tered oxygen at a rate of 2–3 L/min using a nasal catheter
before induction. Propofol (Xi’an Libang Shaanxi, China;
batch number: 1405282) was administered as an IV bolus
by a sub-senior anesthesiologist (13 years of experience)
at 500 (500 ml/h group), 1000 (1000 ml/h group) or
2000 ml/h (2000 ml/h group) to unconsciousness. Upon
loss of consciousness, rapid infusion was stopped. If
the patient still had body movements after infusion, an
additional 20–30 mg of propofol was administered to
avoid body movements during the procedure. The
same senior endoscopist (18 years of experience)
performed all procedures with the help of the same
supervisor nurse (15 years of experience). The endos-
copist had no access to grouping information. The
anesthesiologist that administered the additional propo-
fol was blinded to patient’s history and initial induction
infusion rate.
The target depth of sedation was loss of consciousness,
no response to call, and eyelashes reflection. At this
moment, propofol was stopped and the endoscope was
inserted. If the patients had a body response upon
endoscope insertion, propofol was added. The depth of
sedation was evaluated according to body response and
bispectral index (BIS) values.
Monitoring
An arm vein of the patient was intubated with a 22G
infusion catheter, and non-invasive monitoring of the
arterial pressure was performed with the contralateral
arm. Heart, respiratory, and oxygen saturation (SpO2)
rates were continuously monitored. Induction dose cor-
responded to the drug amount delivered, and the rate
was recorded (Smiths WZ-50F6 two-way injection
pump; Zhejiang Smith Medical Instruments Co., Ltd.,
Ningxia, China). Any excitatory effects or periods of
apnea (>30 s) after induction were recorded. Recovery
time reflected the period from endoscopy end to full
orientation (the patient was able to provide his/her cor-
rect date of birth).
The level of sedation was evaluated using BIS moni-
toring [16–18]. After skin disinfection, disposable elec-
trodes were placed on the forehead, with the leads
connected to a BIS Aspect monitor (Medical System,
USA), whose output was assessed throughout the oper-
ation and recovery. BIS ≤65, 66–85, and >85 indicated
deep, conscious, and mild sedation states, respectively.
BIS levels were recorded at the following times: base-
line, loss of consciousness, endoscope reaching the
glottis, endoscope reaching the duodenum, end of en-
doscopy, and recovery. An independent observer (resi-
dent doctor, 3 years of experience, blind to grouping)
was responsible for monitoring the patients including
level of consciousness and adverse reactions (hypox-
emia, bradycardia, hypotension, body movements,
cough, nausea, hiccough, awareness) and for data col-
lection (drugs, doses, and onset of cardiorespiratory
events).
Adverse events were: hypoxemia (hypoxemia was de-
fined SpO2 falling below 90 %), hypotension (systolic or
diastolic blood pressure values decreasing by 20 % or
more) and bradycardia (heart rate less than 50 bpm).
Severe hypoxemia was defined as SpO2 declining below
90 %, while mild hypoxemia was defined as SpO2 de-
clining below 90 % but rising to above 90 % after more
than 30 s of jaw thrust maneuver.
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As described by Cohen [19], we compared the three
groups with respect to the time to induction (time period
from first drug bolus dose to procedure initiation) and the
time to recovery (time elapsed from endoscope removal to
final evaluation). A patient was discharged only when BIS
levels exceeded 90 and when there was no complaint of
pain or discomfort.
At hospital discharge, a 10-point visual analogue scale
(VAS) was used to evaluate patient satisfaction, from 1
to 10, representing least and most satisfied, respectively.
Additionally, a VAS was used by the endoscopist to rec-
ord his level of satisfaction with the sedation regimen.
Respondents had to circle the number that corresponded
the best to their experience. The endoscopist’s VAS was
scored as 1–3, 4–7, and 8–10 for considerable, minor, and
no difficulty in performing the procedure; respectively.
Data collection
Age, sex, weight, height, ASA physical status, complica-
tions and adverse reactions during endoscopy, patient
VAS score, and endoscopist VAS score were recorded.
The following parameters were recorded during endos-
copy: time to unconsciousness, total propofol dose, pro-
pofol dose (mg.kg−1), duration of endoscopy, recovery
time, and BIS value at baseline, loss of consciousness,
endoscope reaching the glottis, endoscope reaching the
duodenum, end of endoscopy and recovery.
Endpoints
The primary endpoint was the incidence of hypoxemia.
The secondary endpoints were: incidence of adverse events
other than hypoxemia (bradycardia, hypotension, body
movement, cough, nausea, hiccough and, awareness);
satisfaction of the endoscopist with sedation; BIS values;
time to loss of consciousness; total propofol dose; pain
during injection; endoscopy duration; and recovery time.
Statistical analysis
Based on our preliminary experiments, the mean frequency
of hypoxemia (primary outcome) was approximately 12 %
during gastrointestinal endoscopy, and the sample size was
calculated based on reducing this frequency by 50 %. To
achieve 90 % power at an α level of 0.05 to detect a two-
tailed difference, at least 88 patients were required in each
group.
Data were analyzed using SPSS 19.0 (IBM, Armonk,
NY, USA). Continuous data are mean ± standard deviation
(SD). Categorical data were reported as frequencies. One-
way analysis of variance (ANOVA) was employed for
group comparisons, with the post hoc Bonferroni multiple
comparison test. Categorical variables were assessed by
the Pearson’s chi-square test. Two-tailed P-value ≤0.05
was considered statistically significant. Statistical review of
this study was performed by a biomedical statistician
(Tao Zhu).
Results
Characteristics of the patients
A total of 368 individuals were enrolled, with 41 not
meeting the inclusion criteria; 18 withdrew from the
study and 9 were excluded for unknown reasons. All pa-
tients underwent endoscopy for diagnostic procedures.
The remaining 300 patients were randomized into one
of the three groups (Fig. 1). Table 1 presents the charac-
teristics of the patients. Patients were aged 50.1 ± 13.1,
52.0 ± 11.3 and 51.0 ± 11.3 years in the 500, 1000 and
2000 ml/h groups, respectively, and the proportion of fe-
males was 68.4, 72.2 and 64.3 %, respectively (all P > 0.05).
There was no difference in weight, height, ASA class, body
mass index (BMI), and endoscopy history (all P > 0.05).
Time to loss of conscious, dose, duration of endoscopy,
and recovery time
Time to loss of consciousness was significantly longer
with the slower infusion rates (86.4 ± 6.0 vs. 54.1 ± 4.8
vs. 32.4 ± 5.2 s at 500, 1000 and 2000 ml/h, respectively;
all P < 0.01). Total (induction dose + eventual additional
doses) and weight-related induction doses were significantly
less with 500 and 1000 ml/h compared with 2000 ml/h
(2.4 ± 0.4 and 2.4 ± 0.3 vs. 2.9 ± 0.5 mg/kg, P < 0.01). In
comparison with patients treated at 500 ml/h, the duration
of endoscopy was decreased in the 1000 and 2000 ml/h
groups (P < 0.05). However, in comparison with individuals
treated with propofol at 2000 ml/h, recovery times were
shorter in the 500 and 1000 ml/h groups (18.1 ± 2.0 vs.
13.2 ± 1.6 and 13.1 ± 1.6 min, P < 0.05) (Table 2).
Bispectral index values
Compared with the 500 and 1000 ml/h groups, BIS
values were significantly decreased in patients receiving
propofol at 2000 ml/h at loss of consciousness, endoscope
reaching the glottis, endoscope reaching the duodenum
and end of endoscopy (P < 0.01) (Table 3).
Complications and adverse reactions
In comparison with the 2000 ml/h group, the frequencies
of hypotension and hypoxemia were significantly decreased
in patients administered propofol at 500 and 1000 ml/h
(P < 0.01). However, no statistically significant differences
were obtained between groups regarding arrhythmia and
pain during injection (Tables 4 and 5). Compared with the
1000 and 2000 ml/h groups, the frequencies of extremity
motor activity, cough, nausea, hiccough and awareness
were significantly increased in patients treated at 500 ml/h
(P < 0.01) (Table 4). Deep sedation rate was significantly
increased after propofol administration at 2000 ml/h
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compared with the 500 and 1000 ml/h groups (P < 0.01)
(Table 4).
Satisfaction
Mean VAS scores were significantly decreased in pa-
tients treated with propofol at 500 ml/h in comparison
with those receiving the drug at 1000 ml/h (P < 0.01)
and 2000 ml/h (P < 0.05). Average VAS scores for endos-
copist’s satisfaction were significantly increased in the
1000 and 2000 ml/h groups compared with the 500 ml/h
group (P < 0.01) (Table 5).
Discussion
This study aimed to assess three infusion rates of propo-
fol for their impact on sedation and adverse effects for
outpatient upper gastrointestinal endoscopy. Results showed
that the incidences of hypoxemia, hypotension, and deep
sedation and the recovery times were significantly increased
in patients treated at 2000 ml/h in comparison with the 500
and 1000 ml/h groups. Compared with the 500 ml/h group,
motor activity of the extremities, cough, nausea, hiccough,
and awareness were significantly decreased and the mean
scores on the visual analogue scale for endoscopist’s and
Fig. 1 Patient flowchart
Table 1 Characteristics of the patients
Variables 500 ml/h (n = 95) 1000 ml/h (n = 97) 2000 ml/h (n = 98) P-value
Age (years) 50.1 ± 13.1 52 ± 11.3 51 ± 11.3 >0.05
Sex (M/F) 65/30 70/27 63/35 >0.05
Weight (kg) 63.6 ± 11.7 62.5 ± 8.1 61.9 ± 8.8 >0.05
Height (cm) 162.7 ± 7.1 161.9 ± 6.6 161.6 ± 6.7 >0.05
ASA class I/II/III 60/30/5 63/26/8 58/34/6 >0.05
BMI <16 or BMI >30 (kg m−2) 2/5 1/2 3/3 >0.05
Endoscopy history 65 72 70 >0.05
Data are expressed as means ± SD or number of patients. ASA American Society of Anesthesiologists
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patients’ satisfaction were significantly increased in the 1000
and 2000 ml/h groups.
Here, BIS was used as a new way to assess deep sedation
frequency. To improve the sensitivity and specificity, deep
sedation was defined as BIS ≤65 [16–18, 20]. Based on this
definition, deep sedation occurred in 18, 16 and 51 % of
the patients in the 500, 1000 and 2000 ml/h groups, re-
spectively. Although propofol was administered at rates
targeting conscious sedation, deep sedation was often
obtained at 2000 ml/h. However, it should be noted
that BIS monitoring accuracy for detecting deep sed-
ation is still controversial [17]. Differences in BIS values
were observed between the groups at loss of conscious-
ness, endoscope reaching the glottis, endoscope reach-
ing the duodenum and the end of endoscopy. In
addition, a greater decrease in BIS was observed after
treatment at 2000 ml/h in comparison with the 500 and
1000 ml/h groups. Prior to these time points, BIS values
were similar between the three groups. Therefore, it may
be assumed that these differences might result from the
propofol dose used for induction (2.9 mg kg−1) during
procedure initiation. The BIS recordings are reflective of
the previous 15 s of brain activity [18], and BIS values
exhibit good correlation with consciousness [9]. Deep
sedation associated adverse effects were readily alleviated
with common clinical procedures. Although brain propo-
fol amounts were not measured here, the delay from infu-
sion completion and complete response suppression in
the 2000 ml/h group might corroborate findings in sheep
by Ludbrook et al. [21]. Our method eliminated spuriously
high BIS scores that arise from patient stimulation dur-
ing modified observer’s assessment of alertness/sedation
(MOAA/S) scale evaluation. By frequently stimulating the
patient for MOAA/S, the sedation target might require
more medication and a higher MOAA/S score than if the
MOAA/S score were assessed less frequently. The drug
dose and sedation depth were similar when the two
methods were used [22]. In the present study, the patients
were evaluated, and the drugs were adjusted according
to BIS rather than MOAA/S score. BIS is superior to
MOAA/S in simplicity, offering more continuous mea-
surements. It therefore objectively evaluate sedation in
individuals submitted to endoscopy [16].
Low infusion rates in the 500 ml/h group did not abol-
ish patient reflexes although eyelids remained closed,
which probably led to the difference in endoscopy dur-
ation since less movements results in an easier procedure.
Our findings indicate that increased propofol infusion rate
is associated with decreased BIS values, in agreement with
previous studies [20, 23]. Insufficient propofol administra-
tion results in patient excitement, and additional propofol
must be given for endotracheal intubation. Therefore,
there is a need for proper anesthetic amounts during en-
doscopy, prior to the procedure. Slow induction is more
likely to cause excitatory side effects. In the present study,
Table 2 Time to loss of consciousness, dosage, duration of endoscopy, and recovery time
Variables 500 ml/h 1000 ml/h 2000 ml/h
Time to loss of consciousness 86.4 ± 6.0 54.1 ± 4.8* 32.4 ± 5.2*, **
Total propofol dose (induction dose + additional doses) (mg) 155.1 ± 15.4 150.8 ± 12.1 180.1 ± 19.5*, **
Propofol dose (mg.kg−1) 2.4 ± 0.4 2.4 ± 0.3 2.9 ± 0.5*, **
Duration of endoscopy (min) 4.0 ± 0.6 3.4 ± 0.6* 3.5 ± 0.6*
Recovery times (min) 13.2 ± 1.6 13.1 ± 1.6 18.1 ± 2.0*, **
Data are expressed as means ± SD
*P < 0.01 vs. 500 ml/h
**P < 0.01 vs. 1000 ml/h
Table 3 Bispectral index value at different time points
Time points 500 ml/h 1000 ml/h 2000 ml/h
Baseline 96.0 ± 1.7 96.5 ± 1.5 96.1 ± 1.8
Loss of consciousness 80.0 ± 3.8 79.1 ± 3.7 75.9 ± 4.0*, **
Endoscope reaching the glottis 75.8 ± 3.9 74.9 ± 3.5 69.0 ± 2.7*, **
Endoscope reaching the
duodenum
67.0 ± 2.9 68.0 ± 3.0 62.9 ± 4.5*, **
End of endoscopy 71.2 ± 5.6 72.0 ± 5.4 67.8 ± 3.1*, **
Recovery 87.6 ± 1.5 87.8 ± 1.5 87.5 ± 1.5
Data are expressed as means ± SD
*P < 0.01 vs. 500 ml/h
**P < 0.01 vs. 1000 ml/h
Table 4 Complications and adverse reactions during endoscopy
Complications and
adverse reactions
500 ml/h 1000 ml/h 2000 ml/h
Hypoxemia 10 (10.5) 15 (15.4) 40 (40.8)*, **
Arrhythmia 0 (0.0) 1 (1.0) 3 (3.1)
Systolic hypotension 10 (10.5) 14 (14.4) 30 (30.6)*, **
Diastolic hypotension 16 (16.8) 19 (19.6) 45 (45.9)*, **
Extremity motor activity 33 (34.7) 9 (9.3)* 7 (7.1)*
Cough 16 (16.8) 5 (5.2)* 2 (2.0)*
Nausea 19 (20.0) 7 (7.2)* 4 (4.1)*
Hiccough 15 (15.8) 4 (4.1)* 3 (3.1)*
Awareness 17 (17.9) 2 (2.1)* 1 (1.0)*
Deep sedation 18 (18.9) 16 (16.5) 51 (52.0)*, **
Data are expressed as number (%)
*P < 0.01 vs. 500 ml/h
**P < 0.01 vs. 1000 ml/h
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deeper anesthesia was achieved with faster injection, as
indicated by the loss of the eyelash reflex.
Fanti et al. [24] have reported that the most common
complications in gastrointestinal endoscopy were related
to the sedation and not to the procedure itself. These
complications include cardio-respiratory adverse events
such as hypoxemia, hypoventilation, apnea, dysrhythmias,
hypotension and vasovagal episodes [24]. As shown above,
no differences in heart rates among the three groups were
observed.
Hypoxemia incidence rates were 10, 15 and 40 % in
the 500 ml/h, 1000 ml/h and 2000 ml/h groups, respect-
ively, making it the most common complication. How-
ever, hypoxemia responded to oxygen supplementation.
Relatively high transient mild hypoxemia rates in all
groups might result from the close patient monitoring
during sedation. Such data contribute to fueling the de-
bate on the routine administration of supplemental oxy-
gen during upper gastrointestinal endoscopy. The overall
incidence of apnea was 22.4 % as shown above, in agree-
ment with previous studies (20–30 %) [25, 26] assessing
younger subjects with apnea defined as a ventilatory
pause >40 s.
Mild hypotension is a frequent complication of pro-
pofol sedation. The reduction in hypotension frequency
in the 500 and 1000 ml/h groups compared with the
2000 ml/h group is consistent with the results of previ-
ous studies [7–10, 12–14, 27]. This mild hypotension
rarely has adverse clinical consequences and usually
requires no intervention. The hypotensive episodes in
the present study were transient and did not require
pharmacological treatment.
Studies have demonstrated that a slower propofol injec-
tion rate decreases cardiovascular effects ([12–14, 28, 29].
However, slow injection rates might result in longer
induction times [12–14, 30]. As shown above, increased
induction times were observed with lower injection
speeds, corroborating previous studies [12–14, 30, 31].
Here, lower infusion rates caused increased induction
times, resulting in reduced induction doses of propofol,
without differences in the total propofol dose at induc-
tion end. Propofol was administered at 2.4 mg/kg in
average at 500 and 1000 ml/h, which is in the standard
range of 2–2.5 mg/kg [32].
This study has some potential limitations. First, the
patients were exclusively Chinese individuals, and some
conclusions might not be globally generalized. Second,
we did not evaluate the economics or the side effects of
the regimens after the patients were discharged. Third,
all patients received oxygen before induction, and the
controversy about routine oxygen administration [33, 34]
could not be addressed by the present study. Fourth, men
and women were included, and it is well known that there
are gender differences in anesthesia [35]. Fifth, different
levels of sedation depth could be associated different
rates of adverse effects, which could confound the re-
sults. Sixth, only mild/moderate sedation was studied,
and the results may not apply to deep sedation. Seventh,
no cost-effectiveness analysis was performed, but it may
be assumes that optimizing the sedation process should
lead to decrease costs. Eighth, some patients had a history
of endoscopy, which could influence their experience of
subsequent procedures. Finally, we did not follow-up the
patients after discharge to monitor eventual longer-term
adverse effects.
The present study suggests that a propofol infusion
rate of 1000 ml/h appears to be the most appropriate
rate for upper gastrointestinal endoscopy anesthesia,
resulting in fewer adverse effects and improved satis-
faction. Therefore, this rate should be used for upper
gastrointestinal endoscopy anesthesia in selected patients
corresponding to the inclusion criteria of this study. These
results suggests that it is possible to optimize propofol
administration in these patients. Nevertheless, further
studies are necessary to broaden the generalisability of
these results.
Conclusion
In conclusion, a propofol infusion rate of 1000 ml/h
appears to be the most appropriate rate for upper
gastrointestinal endoscopy anesthesia. This rate resulted
in fewer complications and adverse reactions during en-
doscopy, as well as in improved endoscopist satisfaction.
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